HeartSciences Inc. Market Cap ($10.56 Million)
Market Cap & Net Worth: HeartSciences Inc. (HSCS)
HeartSciences Inc. market cap. HeartSciences Inc. (NASDAQ:HSCS) has a market capitalization of $10.56 Million ($10.56 Million) as of November 15, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #26867 globally and #5618 in its home market, demonstrating a -20.41% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying HeartSciences Inc.'s stock price $2.13 by its total outstanding shares 4969283 (4.97 Million). Also see HSCS cash generation efficiency for how efficiently the company converts equity into cash flow.
HeartSciences Inc. Market Cap History (2022–2026)
HeartSciences Inc. market cap history from 2022 to 2026. Data shows change from $417.37 Million to $10.56 Million (-62.92% CAGR). Check HeartSciences Inc. (HSCS) share price today for real-time trading data and today's change.
Index Memberships
HeartSciences Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.74 Trillion | 0.00% | #742 of 976 |
|
NASDAQ Composite
IXIC
|
$40.13 Trillion | 0.00% | #2435 of 3165 |
Weight: HeartSciences Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
HeartSciences Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how HeartSciences Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore HSCS net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2444.95x
HeartSciences Inc.'s market cap is 2444.95 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $417.37 Million | $14.37K | -$4.83 Million | 29038.45x | N/A |
| 2023 | $84.97 Million | $5.15K | -$6.35 Million | 16499.95x | N/A |
| 2024 | $18.98 Million | $18.60K | -$6.61 Million | 1020.57x | N/A |
| 2025 | $15.36 Million | $4.35K | -$8.77 Million | 3529.90x | N/A |
| 2026 | $10.56 Million | $4.32K | -$9.14 Million | 2444.95x | N/A |
Competitor Companies of HSCS by Market Capitalization
Companies near HeartSciences Inc. in the global market cap rankings as of November 15, 2026. Also see how large is HeartSciences Inc.'s balance sheet for a full breakdown of the balance sheet.
Key companies related to HeartSciences Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #122 globally with a market cap of $188.70 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #184 globally with a market cap of $129.18 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #211 globally with a market cap of $117.88 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #122 | Abbott Laboratories | NYSE:ABT | $188.70 Billion | $108.52 |
| #184 | Medtronic PLC | NYSE:MDT | $129.18 Billion | $102.86 |
| #211 | Stryker Corporation | NYSE:SYK | $117.88 Billion | $309.64 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of HeartSciences Inc. (2022–2026)
Market capitalization of HeartSciences Inc. from 2022 to today. Between 2022 and today, HeartSciences Inc.'s market cap moved from $417.37 Million to $ 10.56 Million, with a yearly change of -62.92%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $10.56 Million | -31.23% |
| 2025 | $15.36 Million | -19.11% |
| 2024 | $18.98 Million | -77.66% |
| 2023 | $84.97 Million | -79.64% |
| 2022 | $417.37 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 15th, 2026 the market cap of HeartSciences Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.56 Million USD |
| MoneyControl | $10.56 Million USD |
| MarketWatch | $10.56 Million USD |
| marketcap.company | $10.56 Million USD |
| Reuters | $10.56 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About HeartSciences Inc.
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related… Read more